SCHEMBL19320482

SCHEMBL19320482

C/N=C/c1cc(C(C)(C)C)cc(C(C)(C)C)c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 4/20 0.53
▸ PTGS2 P35354 4/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ HTT P42858 1/20 0.44
▸ ALOX12 P18054 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CA2 P00918 2/20 0.41
▸ CA1 P00915 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ POLB P06746 1/20 0.39
▸ TYR P14679 1/20 0.39
▸ HIF1A Q16665 5/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16210516 1.00 ALOX5 (0.53) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL16210517 1.00 ALOX5 (0.53) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL17511101 0.88 ALOX5 (0.52) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL17511100 0.88 ALOX5 (0.52) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL2775430 0.86 HTT (0.58) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL2775429 0.86 HTT (0.58) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL11521296 0.86 HTT (0.58) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL6118350 0.84 ALOX5 (0.52) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL20835869 0.84 ALOX5 (0.52) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E
SCHEMBL13470911 0.84 ALOX5 (0.52) ALOX5PTGS2SMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760817-B2 Mass polymerizable polycycloolefin compositions containing soluble photoacid generators PROMERUS, LLC (US) 2023-09-19 — — US disclosed
US-11746166-B2 UV active derivatives of pd(AcAc)2L catalyzed polycycloolefin compositions as optical materials PROMERUS, LLC (US) 2023-09-05 — — US disclosed
US-20230265243-A1 DUAL CATALYST SYSTEM FOR MASS VINYL ADDITION AND CATIONIC POLYMERIZABLE COMPOSITIONS PROMERUS, LLC (US) 2023-08-24 — — US disclosed
US-20170255100-A1 DRY FILM STRUCTURE FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2017-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760817-B2 Mass polymerizable polycycloolefin compositions containing soluble photoacid generators PPOX, VCL, PFN1 ALOX5 18/4885PTGS2 2368/4885SMN1; SMN2 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback